AI assistant
Adaptive Biotechnologies Corp — Director's Dealing 2024
Mar 7, 2024
31660_dirs_2024-03-06_b6be818f-6296-41f7-8f3a-13b438fc54c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2024-01-25
Reporting Person: BOBULSKY SUSAN (Chief Commercial Officer, MRD)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 128302 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.98 | 2024-10-13 | Common Stock (5000) | Direct | |
| Stock Option (Right to Buy) | $6.27 | 2027-04-25 | Common Stock (20000) | Direct | |
| Stock Option (Right to Buy) | $6.55 | 2028-04-24 | Common Stock (28750) | Direct | |
| Stock Option (Right to Buy) | $28.32 | 2030-02-27 | Common Stock (13474) | Direct | |
| Stock Option (Right to Buy) | $39.50 | 2030-08-13 | Common Stock (20000) | Direct | |
| Stock Option (Right to Buy) | $43.68 | 2031-03-04 | Common Stock (22894) | Direct | |
| Stock Option (Right to Buy) | $12.14 | 2032-03-04 | Common Stock (102965) | Direct | |
| Stock Option (Right to Buy) | $8.46 | 2033-03-06 | Common Stock (88689) | Direct |
Footnotes
F1: The options are fully exercisable.
F2: The options will vest with respect to 1/4 of such shares on February 27, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3: The options will vest with respect to 1/4 of such shares on August 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4: The options will vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F5: The options will vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F6: The options will vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.